Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	36.63	48.76	94.09	231.64	272.35	306.02
Short-Term Investments	311.61	301.61	295.22	234.18	125.98	-
Cash & Short-Term Investments	348.24	350.37	389.31	465.82	398.33	306.02
Cash Growth	3.32%	-10.00%	-16.43%	16.94%	30.16%	143.15%
Accounts Receivable	36.48	24.09	13.48	15.41	-	-
Other Receivables	-	0.7	1.1	-	-	0.37
Receivables	36.48	24.79	14.58	15.41	-	0.37
Inventory	38.71	39.71	24.75	19.33	13.93	-
Prepaid Expenses	9.63	9.49	13.58	11.71	5.76	8.75
Restricted Cash	0.51	0.12	0.08	0.26	-	-
Other Current Assets	6.89	0.33	0.23	0.8	1.42	-
Total Current Assets	440.46	424.8	442.54	513.32	419.43	315.14
Property, Plant & Equipment	103.53	116.57	8.56	9.8	10.28	0.09
Long-Term Investments	-	0.2	-	-	24.38	-
Other Intangible Assets	4.51	4.98	6.43	8.4	9.33	8.86
Other Long-Term Assets	0.87	1.52	13.34	11.84	0.25	0.21
Total Assets	549.36	548.06	470.86	543.37	463.66	324.3
Accounts Payable	8.88	4.33	3.09	3.88	2.64	4.15
Accrued Expenses	46.71	49.4	36.28	30.25	22.16	7.02
Current Portion of Leases	15.95	15.6	0.94	1.06	0.79	-
Current Income Taxes Payable	1.01	0.67	0.63	0.81	-	-
Current Unearned Revenue	4.3	4.81	3.15	0.19	-	-
Other Current Liabilities	1.77	2.39	2.03	4.45	6.41	0.12
Total Current Liabilities	78.61	77.19	46.11	40.65	32	11.3
Long-Term Leases	71.91	82.01	7.15	7.68	7.62	-
Other Long-Term Liabilities	10.84	10.91	12.17	15.95	16.3	14.41
Total Liabilities	161.36	170.11	65.43	64.28	55.91	25.7
Common Stock	1,207	1,200	1,185	1,177	944.33	746.49
Additional Paid-In Capital	119.77	120.79	85.49	59.01	39.38	25.39
Retained Earnings	-938	-942.32	-864.3	-756.12	-575.16	-472.48
Comprehensive Income & Other	-0.39	-0.73	-1.06	-0.85	-0.81	-0.81
Shareholders' Equity	388	377.95	405.44	479.09	407.75	298.6
Total Liabilities & Equity	549.36	548.06	470.86	543.37	463.66	324.3
Total Debt	87.85	97.61	8.09	8.74	8.41	-
Net Cash (Debt)	260.38	252.76	381.22	457.08	389.92	306.02
Net Cash Growth	6.78%	-33.70%	-16.60%	17.22%	27.42%	143.15%
Net Cash Per Share	1.82	1.76	2.69	3.53	3.29	3.29
Filing Date Shares Outstanding	143.18	144.62	142.58	141.65	127.45	112.3
Total Common Shares Outstanding	143.11	143.83	142.27	141.6	126.73	111.8
Working Capital	361.85	347.61	396.43	472.68	387.43	303.84
Book Value Per Share	2.71	2.63	2.85	3.38	3.22	2.67
Tangible Book Value	383.49	372.98	399.01	470.69	398.42	289.74
Tangible Book Value Per Share	2.68	2.59	2.80	3.32	3.14	2.59
Machinery	2.02	2.02	1.87	1.88	0.46	0.22
Construction In Progress	-	-	0.26	0.39	4.47	-
Leasehold Improvements	3.24	3.24	2.98	2.98	0.03	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.